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ABSTRACT 
 
 
Nuclear receptors (NRs) include 49 members and belong to family that function as ligand-
inducible transcription factors. The basic structure of nuclear receptors involves the n-
terminal transactivation domain and c-terminal ligand binding domain. Transactivation 
domain that is DNA binding domain contains highly conserved zinc finger region whereas 
ligand binding domain is responsible for the transactivation within the targeted tissue. It has 
been reported that PPARγ, one of the nuclear receptor play an important role in 
mycobacterial infection. Mycobacterium tuberculosis is the bug that causes tuberculosis 
which is one of the deadly diseases of humankind. This bacterium gains entry through air 
passage and internalized by alveolar macrophages for efficient clearance. In spite of these 
barriers, bug has the tremendous ability to abrogate these responses for its own multiplication 
like inhibition of autophagy. Autophagy is one of the host defence mechanisms that have 
gained popularity in last 4-5 years for their anti-microbial responses. Various factors like 
ATP, Vitamin D and cytokines have been shown to induce autophagy. ATP is reported to 
induce autophagy by increasing intracellular calcium level. In our lab we are trying to study 
the response of one of the calcium ionophore that increases intracellular calcium level, 
Calcimycin in inducing autophagy in THP-1 cells. So, in this study we tried to link the role of 
calcimycin induced autophagy with the expression of another nuclear factor, HNF-4α.         
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INTRODUCTION 
 
Nuclear receptor binds to non - polar regulatory molecules that are activated by ligands. 
These are the proteins and they belong to a family which contains transcription factors which 
are highly conserved. Transcription is regulated by the nuclear receptor in response to small 
lipophilic compounds. There are three domains in case of nuclear receptors:  
 Ligand binding domain (LBD) 
 Transcriptional regulation domain 
 DNA binding domain (DBD) 
                 
Figure 1: Structure of nuclear receptor (Adapted from: 1) 
The DNA binding domain (DBD) binds to specific DNA sequences whereas LBD targets 
small lipophilic ligands. These two domains of the nuclear receptors are the highly conserved 
domains. Zinc motifs are present in the N - terminal of the DBD (1). There are 48 nuclear 
receptors known in human genome. Out of which ligand dependent transcription factors are 
24. Since, it has an important role in the discovery of various drugs and controls the functions 
related to various diseases such as diabetes, cancer, infertility and obesity etc. hence, we can 
say that nuclear receptors helps to reach the pharmacological targets. The metabolic and 
reproductive diseases are the result of dysfunctioning of the nuclear receptors (2). There are 
many organisms that live in our bodies which are harmless or even helpful but sometimes 
under certain conditions they show they harmful effect and some organisms may cause some 
diseases. The disorders caused by the organisms like viruses, parasites, bacteria and fungi are 
known as infectious diseases. These infectious diseases can be transmitted from one person to 
another person. Fever and fatigue are the common symptoms of the infectious diseases. Other 
symptoms vary depending on the organism causing the infection. There are various infectious 
diseases like influenza, smallpox, chickenpox, measles, avian influenza and tuberculosis 
(T.B.) etc. and these diseases can be prevented through vaccines. 
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T.B. is most common infectious and dangerous disease and Mycobacterium tuberculosis (M. 
tb) is it’s the causative agent. T.B. was one of the most devastating diseases and it was first 
explained in 1882 by Robert Koch. Recently it has been found that the expression of PPARγ 
increases due to Mycobacterial infection. PPARγ is one of the types of nuclear receptor. Due 
to increase in expression of PPARγ, the formation of lipid droplet also increases and the 
response shown by the macrophage decreases, this might helps the Mycobacteria in escaping 
from the host immune mechanism. Whereas, when the expression of the PPARγ is inhibited 
the capacity to eliminate the Mycobacteria through macrophages increases. This suggests that 
PPARγ plays an important role in the chronic infection (3, 4).  
Phagosome maturation pathway is interfered through M. tb in host phagocytic cell, since it is 
an intracellular pathogen which persist within the phagosomes because of which the 
phagosome - lysosome fusion is inhibited. Hence, M. tb prevents itself from the antigen-
processing and bactericidal environment of phagolysosome (5). Autophagy is involved in 
nutrient regeneration, protein and organelle degeneration but also in clearance of intracellular 
pathogens such as M. tb. There are mainly three forms of autophagy such as macroautophagy, 
microautophagy and chaperone mediated autophagy. In case of macroautophagy mainly 
damaged cell organelles or unused proteins are removed. There is a formation of double 
membrane around cytoplasmic substrates. In case of macroautophagy which results in the 
formation of Autophagosome. Autophagosome fuse with the lysosome and the contents are 
degraded via acidic lysosomal hydrolases. In case of microautophagy the cytoplasmic 
materials are directly engulfed into the lysosome through inward folding of the lysosomal 
membrane. Chaperone-mediated autophagy involves the hsc-70 containing complex 
recognition. Because of this substrate/chaperone complex is formed due to binding of protein 
with that of the chaperone. After entering into the cell the substrate protein gets unfolded and 
it is translocated across the lysosomal membrane in the presence of lysosomal hsc-70 
chaperone. This process of autophagy is extremely selective. Calcium signaling regulates the 
autophagy. ER stress induction also initiates the autophagy. Negative regulation of 
AKT/TSC/mTOR pathway leads to formation of Autophagosome which in turn increases the 
autophagy through ER stress. Calcimycin is a calcium ionophore which increases the calcium 
ion concentration. Therefore in this study we try to interlink the connection between 
calcimycin mediated autophagy and nuclear receptor mainly HNF-4α. 
 
10 | P a g e  
 
REVIEW OF LITERATURE 
 
NUCLEAR RECEPTORS 
Nuclear receptors are the intracellular transcriptional protein which is an important factor for 
the expression of gene in response to lipophilic molecules. Key role is played by the nuclear 
receptors in the study of many diseases like cancer, diabetes and obesity etc. they are also 
important for metabolism and cell death, for maintaining the cellular phenotypes and also 
essential for the development of embryo. If the nuclear receptors will not function properly 
then this will leads to certain metabolic and reproductive diseases like diabetes, infertility, 
obesity and cancer etc. (3). Lipophilic hormones are suitable to serve as regulators for the 
control of gene expression because they are able to diffuse from a source and permeate to a 
target. There are several kinds of lipophilic hormones such as steroid, vitamin D3, thyroid 
hormones and retinoid etc. (6). By the middle of the century glucocorticoids became a 
popular therapeutic agent and also many of lipophilic hormones were related with various 
human diseases (6). According to the classical steroid hormone action model, some allosteric 
changes occurs due to binding of hormones to its receptor as a result of which hormone 
receptor complex binds to the high affinity sites in chromatin and which starts the process of 
transcription. We can broadly divide nuclear receptors into four classes: 
 Class I receptor 
 Contains steroid hormone receptors and function as ligand induced 
homodimers. 
 Also includes androgen (AR), progestin (PR), estrogen (ER), glucocorticoids 
(GR) etc. 
 Class II receptor 
 They contain all retinoic acid receptor, RAR, vitamin D3 and retinoid X 
receptor, RXR. 
 Also includes hetrodimerization with RXR when ligands are absent some of 
these receptors acts as repressors.  
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 Class III receptor 
 These bind to direct repeats as homodimers and also called as orphan 
receptors. 
 Class IV receptor 
 Binds to extended core sites as monomers. 
 
Figure 2: Nuclear receptor subfamily (Adapted From: 7). 
 HNF - 4A gene encodes HNF - 4α (Hepatocyte nuclear factor 4 alpha) nuclear receptor 
protein in human. It is also known as NR2A (nuclear receptor subfamily 2, group A, member 
1). It binds to DNA as a homodimers. The major targets of this gene are intestines, liver and 
kidney (8, 9). Expression of HNF4-α can be up regulated through alkaloid berberine. 
Any changes or mutation in HNF4-α gene decreases the amount of insulin produced which 
leads to diabetes. 
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MAIN ROLE OF NUCLEAR RECEPTORS: 
 The regulatory signals are propagated within the effector cell from outside through 
nuclear receptor. 
 Homeostasis is maintained and also helps to adapt to the changes. 
 Function as a key factor in the development of drugs. 
 Act as a transcription factors by controlling the cellular process by regulating the 
targeted gene expression. As a result synthesis of specific mRNA takes place due to 
which specific protein synthesis occurs, so that the targeted cells activity are regulated 
(10). 
 Also plays a major role in the embryonic development. 
INFECTIUOS DISEASES 
There are several infectious agents that cause infectious diseases such as protozoan, fungus, 
bacteria, virus and helminths. These infectious agents cause disease like smallpox, influenza, 
bird flu, AIDS and T.B. etc. T.B. is the most common and dangerous infectious diseases. The 
causative agent of tuberculosis is M. tb. T.B. spreads by droplet transmission, via the air 
when a contaminated patient coughs or sneeze. Humans are the reservoirs for this bacterium. 
M. tb is a non-motile rod shaped and a intracellular parasite, usually of macrophages (11). 
The bacterium used to reside in our alveoli (in lungs) and remain dormant throughout a long 
time. A host can carry this particular bacterium throughout his life without any apparent 
symptoms but in certain individuals it may reactivate to cause the disease. Usually the bug 
resides inside the phagocytic cells or macrophages. Our immune system is well equipped to 
protect us against different bacterial cells or infection and important component of this 
system is macrophages. For the growth and survival of M. tb, macrophages act as a host cell 
niche. Macrophages phagocytose all those bacteria like Mycobacterium and have the 
capability to kill the same after internalization. But M. tb hijack these immune system cells 
for its own multiplication and growth (12). By this virtue, bug attains the power of staying 
inside the cells for long time without being degraded by the host cell machinery by 
suppressing various host defence mechanisms like inhibition of autophagy.  
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NUCLEAR RECEPTORS PLAYS AN IMPORTANT ROLE IN 
AUTOPHAGY 
Autophagy is a mechanism which affects the immune responses. It is a cell autonomous 
defense mechanism which acts against M. tb. There are several factors such as “Atg proteins” 
like Atg5 and Beclin1 (Atg6) responsible for the execution of the process of autophagy. 
Autophagy is the process which kills the intracellular M. tb. One of the most important roles 
of autophagy is presentation and processing of antigen. These are modulated by cytokines 
and T helper type 1 cytokines like tumour necrosis factor (TNF)-α and interferon (INF)-γ that 
stimulates autophagy. Th2 cytokines interleukin (IL)-4, IL-13 and IL–10 inhibits the 
autophagy. Other factors like Vitamin D, NOD-like receptor 2 (NLR-2), Toll- like receptor 
(TLR) and ATP have been shown to induce autophagy. The expression of cathelicidin 
increases through binding of vitamin D to the vitamin D receptors (13). Cathelicidin are the 
antimicrobial peptide and have the ability to kill the M. tb (14). Autophagy can also be 
induced by vitamin D through cathelicidin in human monocytes and macrophages. Calcitriol 
(1, 25 vitamin D3) is produced in kidney and at a very low concentration it circulates in the 
serum. IFN-γ induced autophagy requires Calcitriol (15). Calcitriol can be produced through 
its precursor 2, 5–hydroxyl vitamin D.  
Beclin 1 and Atg5 are the important factors for the IFN-γ and Calcitriol induced autophagy in 
human cells (15). The IFN-γ plus Calcitriol induce autophagy in human cells promotes 
maturation of phagosomes harbouring M. tb and facilitates their fusion with lysosomal 
compartments that contain antimicrobial peptide (16). 
NLR-2 is also known for the induction of autophagy. Intracellular NLR-2 recognises M. tb 
and regulates secretion of IL-1β (17). 
Engagement of NLR-2 by muramyl dipeptide activates autophagy, promotes bacterial 
trafficking to the autophagolysosome and enhances antigen presentation (18). On the entry of 
the bacteria the Atg16L1 recruitment to the plasma membrane is done through Nucleotide-
binding oligomerization domain-containing protein 2 (NOD 2) (19). ATP has also been 
shown to induce autophagy by increasing intracellular calcium level.   
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Calcimycin is a calcium ionophore that increases intracellular calcium level and it forms 
stable complexes with ions having charge of +2 and can be obtained by fermentation of 
Streptomyces chartreusensis. Its molecular formula is C29H37N3O6 and it is also having 
antibiotics properties against gram positive bacteria and fungi. Calcimycin inhibits 
mitochondrial ATPase activity and in some cells it induces apoptosis. Calcimycin is 
commercially available as free acid, Ca2+ salt. The IUPAC name of Calcimycin is 5-
(methylamino)-2-[[(2S,3R,5R,8S,9S)-3,5,9-trimethyl-2-[1-oxo-1-(1H-pyrrol-2-yl)propan 2-
yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid. 
         
Figure 4: calcimycin structure 
Figure 3: PI3 kinase hVPS34 executes the process of autophagy and at initiation P13- 
phosphate is formed. Autophagy also requires the Beclin (Atg6) which is the subunit of 
Hvps34 complex. Autophagosome wraps around organelles or a phagosome containing 
Mycobacteria. Due to Atg factors, the membrane of the Autophagosome elongates and bends 
to form two complexes. One is Atg5 which is conjugated to Atg12 and the other is Atg8 
which conjugated to PE (phosphatidylethanolamine). 
Adapted from:  (20) 
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Adapted from: www.wikipedia.com 
PPARγ expression has been reported to increase during mycobacterial infection. PPARγ is 
one of the types of nuclear receptor. Due to increase in expression of PPARγ, the formation 
of lipid droplet also increases and the response shown by the macrophage decreases might 
helps the mycobacteria in escaping from the host immune mechanism (21). Whereas when 
the expression of the PPARγ is inhibited the removal of the mycobacterium increases by 
macrophages. This suggests that PPARγ plays an important role in the chronic infection.  
In our study, we tried to elucidate the role of calcimycin induced autophagy on HNF-4 
expression in THP-1 cells.    
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OBJECTIVES OF MY WORK  
1) To see Calcimycin effect on the viability of THP-1 cells. 
2) To see non-cytotoxic effect of Calcimycin concentration on HNF-4α expression. 
3) To see the interplay between calcimycin induced autophagy and HNF-4expression. 
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MATERIALS AND METHODS 
 
 CELL LINES 
Cell line used in the study, THP-1 was a kind gift from Dr. Vivek Rai, Institute of Life 
Science (Bhubaneswar, India). Cells were maintained in RPMI-1640 growth medium, 
containing 10% heat inactivated FBS (Fetal bovine serum) and antibiotic cocktail (1X 
streptomycin and penicillin), at 37°Cin the presence of 5% CO2. It is now well reported in the 
literature that THP-1 cells behave like human monocyte derived macrophages (MDM) in 
many ways (Stokes et al., 1999). 
 
CHEMICALS 
All the chemicals used in this study were of analytical grade and obtained from commercial 
sources. FBS and RPMI-1640 was purchased from GIBCO (Grand Island, NY). Antibiotic 
was purchased from GIBCO (Grand Island, NY). ECL western blotting detection reagents 
and analysis system was purchased from GE healthcare (UK). MTT cell assay kit was 
purchased from HiMedia Laboratory (Mumbai, India). BCA kit was purchased from Sigma 
Sigma-Aldrich.  Following reagents were purchased from HiMedia Laboratory (Mumbai, 
India): Sodium chloride (NaCl), Sodium dodecyl sulfate(SDS), Acrylamide, Dimethyl 
sulfoxide (DMSO), hydrochloric acid (HCL), Tris base, Glycine, potassium chloride (KCl), 
Potassium Dihydrogen Phosphate (KH2PO4), Disodium phosphate (Na2HPO4), Ethylene 
diamine tetra acetic acid (EDTA), Triton X-100, glycerol, 2-mercaptoehtanol, Bromophenol 
blue,  Sodium hydroxide (NaOH), Phorbol myristate acetate (PMA) and Bovine serum 
albumin (BSA).Following reagents were purchased from Sigma (St. Louis, Mo, USA): 
Bisacrylamide, Calcimycin and Sodium deoxycholate. All media and reagents used were 
endotoxin-free. 
 
CELL CULUTURE MEDIA 
Complete RPMI-1640 (with antibiotic) 
RPMI media     500ml 
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FBS      50ml 
Penicillin-Streptomycin (1X)   5.5ml  
50 ml of heat inactivated FBS was added to RPMI medium. 5.5 ml of Penicillin-Streptomycin 
was added. Aliquots of 100 ml were prepared and stored at 4ºC.  
 
 BUFFER/ SOLUTIONS 
10 X Phosphate Buffered Saline (pH 7.4) 
NaCl     80.0 g    
KCl     2.0 g 
Na2HPO4    14.4 g 
KH2PO4    2.4 g 
The above components were dissolved in 800 ml of double-distilled water and pH was 
adjusted to 7.4 with HCl (0.1M). Final volume was made to 1 litter with double-distilled 
water. 
1 M Tris (pH 6.8 or 7.4 or 8.0 or 9.0)  
Tris base    121.1 g 
Tris base was dissolved in 800 ml of double-distilled water and the pH was adjusted to the 
desired value by adding concentrated HCl (0.1M). The volume of the solution is adjusted to 1 
litter. 
Reservoir Buffer 10X (For SDS-PAGE electrophoresis) 
Tris base     3.0 g 
Glycine     14.4 g 
10% SDS    10.0 ml 
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Above compounds were dissolved in 990 ml of double-distilled water and 10 ml of 10% SDS 
was added 
4 X Protein Sample buffer (For SDS-PAGE electrophoresis) 
Upper Tris (1 M, pH – 6.8)  2.4 ml 
SDS     0.8 g 
Glycerol     4.0 ml 
β-Mercaptoethanol   0.5 ml 
Bromophenol blue   4 mg 
Above components were dissolved in 3.1 ml of distilled water and final volume was made to 
10 ml. The solution was dispensed into aliquots and stored at –20°C. 
Transfer Buffer10X (For Western blotting) 
Tris base     10.8 g 
Glycine     50.7 g 
Above compounds were dissolved in 250 ml of distilled water and the final volume was made 
360 ml by adding distilled water. The solution is sterilized by autoclaving. 300 ml of 
methanol was added to 1200 ml of 1X transfer buffer.   
Acrylamide - bis-Acrylamide mixture 
Acrylamide    30.0 g 
Bis-Acrylamide   0.8 g 
Acrylamide and bis-Acrylamide were dissolved in 70 ml double-distilled water final volume 
was adjusted to 100 ml. Then the solution is filtered and stored in -4°C. 
10% Sodium dodecyl sulfate (SDS) 
SDS     5 g 
SDS was dissolved in 40 ml of double distilled water. The volume was adjusted to 50 ml with 
double distilled water. 
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10% APS 
APS     0.1 g 
0.1g APS was dissolved in 1ml distilled water. 
PBS-T (For Western blotting) 
10 X PBS    50.0 ml  
Tween-20     2.5 ml 
Distilled water    450.0 ml 
These were mixed with distilled water. 
Lower Tris (4 X) pH 8.8 (For SDS-PAGE electrophoresis) 
Tris base    18.17 g 
10% SDS    4.0 ml 
Tris base was dissolved in 80 ml of double-distilled water and pH was adjusted to 8.8 using 
0.1N HCl. Then 4 ml of 10% SDS was added and the final volume was made to 100 ml with 
double-distilled water.    
Upper Tris (4 X) pH 6.8 (For SDS-PAGE electrophoresis) 
Tris base    6.06 g 
10% SDS    4.0 ml 
Tris base was dissolved in 25 ml of double distilled water and pH was adjusted to 6.8 using 
0.1N HCl. Then 4 ml of 10% SDS was added and the final volume was made to 100 ml with 
double-distilled water. 
RIPA buffer 
1% Triton X – 100   1 ml 
150 mM NaCl    1.5 ml 
0.5% Sodium deoxycholate  0.5 ml 
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50 mM Tris, pH – 8.0   0.5 ml 
0.1 % SDS    0.1 ml 
Protease inhibitor cocktail (1X) 0.1 ml 
Distilled water    6.3 ml 
 All the components were added to distilled water except protease inhibitor cocktail (PIC) and 
the final volume of the solution was made to 9.9 ml by adding distilled water. PIC was added 
fresh to the solution. 
5% SKIM MILK (For Western blotting) 
Skim milk   5 g 
PBS-T    100 ml 
5g skim milk was dissolved in 100ml PBS-T. 
  
METHODS 
  
CELL CULTURE 
The human monocytic cell line, THP-1 was obtained from ILS, Bhubaneswar. It was cultured 
in RPMI-1640 (Gibco Laboratories, USA) containing 10% heat inactivated FBS at 37°C in 
the presence of 5% CO2. Culture medium was changed when cell density was increased and 
pH became acidic. For changing the media, cells were centrifuged at 1000 rpm for 5 min and 
supernatant was discarded. Pellet was resuspended in 5 ml of fresh medium and transferred to 
the flask.  
 
CELL VIABILITY  
Cell viability assay was done using MTT cell viability kit according to the protocol supplied 
by the manufacturer. Briefly, 2.5×104 cells were seeded in triplicate overnight in the presence 
of PMA in each well of in 96-well plate. Next day, cells were washed and treated with 
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varying concentration of Calcimycin for 24, 48 and 72 h. At appropriate time point, 10l of 
MTT was added in each well. Plate was gently swirled to mix the contents and incubated for 
2-4 h at 37C. Formazan crystals were formed and dissolved in 100 μl of lysis solution. For 
blank, cell lysis solution was added before adding MTT. The absorbance was read at 562 nm 
in plate reader. 
The cell viability was calculated according to following formula: 
% Cell viability = (OD of Test sample/OD of Control) x 100. 
 
 WESTERN BLOTTING  
50 g of protein from cell lysates after protein estimation by BCA reagent was 
electrophoresed on 15% SDS-PAGE. Protein bands were transferred to nitrocellulose 
membrane, blocked with skimmed milk followed by probing with anti-LC3 (Primary 
antibody) antibody that recognizes LC3-I and LC3-II bands for overnight at 4°C and later 
with secondary antibody for 45 min. at room temperature. Protein bands were visualized 
using enhanced chemiluminescence kit (Amersham, USA) as per manufacturer’s instructions. 
Between each step membrane was washed three times with PBS-T. Blots were stripped and 
reprobed with β-actin antibody following same protocol as above for using as a loading 
control.  
 
CELL LYSIS 
10 µl of 100X PIC (protease inhibitor cocktail) is added in 1 ml of RIPA buffer for preparing 
cell lysis buffer. At appropriate time point, the supernatant of the cultured cells was removed 
and cells were washed twice with 1X PBS. Then cells were lysed in the wells with 0.1 ml of 
cell lysis buffer. Cell lysates were then transferred to ice-chilled micro centrifuge tubes. 
Tubes were then kept on ice for 30 minutes with intermittent vortexing after every 10 
minutes. Tubes were then centrifuged at 15000 rpm for 15 min at 4C and supernatants were 
dispensed into aliquots and stored at -20C till protein estimation and SDS-PAGE 
electrophoresis. 
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PROTEIN ESTIMATION BY BCA REAGENT 
Protein concentration of the sample was determined using BCA kit according to the protocol 
supplied by the manufacturer. Briefly, according to the number of samples, 1:50 BCA 
working solution was prepared and mixed with 5 l of standards, blank and test cell lysate 
samples in 96-well plate. Plate was incubated for 15-20 min at 37C before taking absorbance 
at 562 nm. Readings were calculated and protein was estimated.  
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RESULT 
 
 Calcimycin kills THP-1 cells at a concentration more than 0.8 µM at 24 h 
of treatment 
 PMA differentiated THP-1 cells were treated with different concentration of Calcimycin 
(0.001-1.0 µM) for 24 h. Cell viability was decreased to 74.14 ± 6.6% at 1 µM Calcimycin as 
shown by MTT assay in Figs. 5 and 8. 
0
20
40
60
80
100
120
DMSO                       -   +    -    -   -    -    -    -    -    -    -   -
Calcimycin (M)        -    - .001 .005 .01 .05  0.1  0.2  0.4 0.6  0.8  1.0
      24 h
n=3
%
 V
ia
b
ili
ty
 
 
Figure 5: Effect of varying concentration of Calcimycin on cell viability of 
THP-1 cells after 24 h of treatment.  The cytotoxicity was measured by MTT assay 
as described in materials and method. Briefly, THP-1 cells were seeded in triplicate in 96 
well plates and differentiated over night with 50 ng/µl of PMA. Next day cells were washed 
and subjected to different concentration of Calcimycin as shown in the figure after 24 h of 
treatment, MTT was added and cells were incubated for 3 h. After incubation, cell lysis 
buffer was added and OD was taken at 562 nm. Data are expressed as percentage cell 
viability over control cells. 
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Calcimycin kills THP-1 cells at concentration more than 0.6 µM at 48 h of 
treatment 
PMA differentiated THP-1 cells were treated with different concentration of Calcimycin 
(0.001-1.0 µM) for 48 h. Cell viability was decreased to 83.07 ± 4.8% and 59.7 ± 2.6% at 0.8 
µM and 1µM Calcimycin respectively as shown by MTT assay in Figs. 6 and 8.   
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Figure 6: Effect of varying concentration of Calcimycin on cell viability of 
THP-1 cells after 48 h of treatment. MTT assay was employed to check the all 
viability. Briefly as written in pervious legend differentiated THP-1 cells were treated with 
Calcimycin for 48 h. After 48 h, MTT reagent was added, plates were incubated for 3 h and 
then lysis buffer was added. OD was taken at 562 nm. Data are expressed as percentage cell 
viability over control cells.  
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 Calcimycin kills THP-1 cells at a concentration more than 0.4 µM at 72 h 
of treatment 
PMA differentiated THP-1 cells were treated with different concentration of Calcimycin 
(0.001-1.0 µM) for 72 h. Cell viability was decreased to 80.32 ± 4.6%, 68.03 ± 3.7% and 
50.01 ± 2.2% at 0.6 µM, 0.8 µM and 1 µM Calcimycin as shown by MTT assay in Figs. 7 
and 8. 
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Figure 7: Effect of varying concentration of Calcimycin on cell viability of 
THP-1 cells after 72 h of treatment. MTT assay was employed to check the cell 
viability. Briefly, as stated above, differentiated THP-1 cells were treated with Calcimycin 
for 72 h. After 72 h, MTT reagent was added, plates were incubated for 3 h and then lysis 
buffer was added. OD was taken at 562 nm. Data are expressed as percentage cell viability 
over control cells. 
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Figure 8: Effect of varying concentration of Calcimycin on cell viability of 
THP-1 cells after 24, 48 and 72 h of treatment. MTT assay was employed to check 
the cell viability. Briefly, as written above, differentiated THP-1 cells were treated with 
Calcimycin for 24, 48 and 72 h. At appropriate time points, cell viability was measured by 
taking OD at 562 nm. Data are expressed as percentage cell viability over control cells. 
 
Calcimycin treatment increases HNF-4α expression in THP-1 cells. 
PMA differentiated THP-1 cells were treated with 400 mM of Calcimycin. After 48 h cell 
lysates were prepared and western blotting was done to detect HNF-4α expression upon 
Calcimycin treatment. 
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Figure 9: Effect of calcimycin (0.4 μM) on HNF-4α  expression in 
differentiated THP-1 cells at 48 h of treatment. PMA differentiated THP-1 cells 
were treated with calcimycin (0.4 μM). After 48 h of treatment, whole cell lysates were 
electrophoresed and western blotting was done to detect the HNF-4α expression. Blot was 
stripped and for loading control, β-actin expression was detected using anti- β-actin antibody. 
 
The non-toxic concentration of Calcimycin (0.4 µM) has an effect on 
autophagy in PMA differentiated THP-1 cells. 
The effect of non-cytotoxic concentration of Calcimycin (0.4 µM) on autophagy in 
differentiated THP-1 cells was studied by western blotting. We found that Calcimycin 
treatment led to accumulation of LC-3-II in THP-1 cells compared to untreated cells. This 
result suggests that Calcimycin is a potent inducer of autophagy in THP-1 cells. 
 
 
 
 Figure 10: Effect of Calcimycin (0.4 μM) on LC-3 degradation in 
differentiated THP-1 cells at 48 h of treatment. Differentiated THP-1 cells were 
treated with 0.4 µM of Calcimycin. After 48 h, whole cell lysates were prepared as described 
in materials and methods. Lysates were subjected to western blotting with anti-LC3 antibody 
(upper panel). Blot was stripped and for loading control β-actin expression was detected 
using anti-β-actin antibody. 
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3-MA abrogates Calcimycin induced HNF-4α expression in THP-1 cells. 
In differentiated THP-1 cells 3-MA, an autophagy inhibitor was used to see the role of 
autophagy in HNF-4α expression. We found that addition of 3-MA inhibits the Calcimycin 
induced HNF-4α expression in THP-1 cells.  
 
 
 
 
Figure 11: Effect of Calcimycin and 3-MA on HNF-4α expression in THP-1 
cells. PMA differentiated THP-1 cells were pre-treated with 3-MA (Methyl Adenine) before 
treating with Calcimycin (400 nM). After 48 h of Calcimycin treatment, whole cell lysates 
were prepared. Cell lysates were then electrophoresed and western blotting was done to 
detect HNF-4α expression. Blot was stripped and for loading control β-actin expression was 
detected using anti-β-actin antibody. 
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DISCUSSION 
Various inducers of autophagy are being discovered every day. Amongst important 
autophagy inducers, ATP has been shown to belong to these classes of compounds by 
increasing intracellular calcium level. 
In our lab we are currently using Calcimycin, an calcium ionophore to study its 
antimycobacterial effect. Nuclear factor like PPARγ has been shown to play an important role 
in tuberculosis. In one of the experiment we found increased expression of HNF-4α in THP-1 
cell line upon Calcimycin treatment. This result is surprising because THP-1 cells share close 
proximity to human alveolar macrophages and HNF-4α expression has been shown in 
literature to be limited in the organs like liver and kidney. 
Since we found Calcimycin induces autophagy in THP-1 cells so to further see the interplay 
between Calcimycin induced autophagy and HNF-4α expression we used autophagy inhibitor 
(3-MA)in the presence and absence of Calcimycin. We found that 3-MA abolished the HNF-
4α expression induced by Calcimycin. Clearly suggesting autophagy regulates HNF-4α 
expression in THP-1 cells. Further experiments are required to elucidate the mechanism of 
HNF-4α expression in the presence of Calcimycin and its role in tuberculosis.   
 
 
CONCLUSION 
1) Concentration 0.4 μΜ of Calcimycin didn’t show any cytotoxicity in THP-1 cells 
after 24, 48 and 72 h of treatment. 
2) 0.4 μΜ of Calcimycin induced HNF-4α expression in THP-1 cells. 
3) Autophagy inhibitor (3-MA) abolished the increased HNF-4α expression by 
Calcimycin. 
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